Literature DB >> 27344645

A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV.

Haiqing Yi1, Quan Zhang1,2, Chunyu Yang1, Priya S Kishnani1, Baodong Sun3.   

Abstract

Deficiency of glycogen branching enzyme in glycogen storage disease type IV (GSD IV) results in accumulation of less-branched and poorly soluble polysaccharides (polyglucosan bodies) in multiple tissues. Standard enzymatic method, when used to quantify glycogen content in GSD IV tissues, causes significant loss of the polysaccharides during preparation of tissue lysates. We report a modified method including an extra boiling step to dissolve the insoluble glycogen, ultimately preserving the glycogen content in tissue homogenates from GSD IV mice. Muscle tissues from wild-type, GSD II and GSD IV mice and GSD III dogs were homogenized in cold water, and homogenate of each tissue was divided into two parts. One part was immediately clarified by centrifugation at 4°C (STD-prep); the other part was boiled for 5 min then centrifuged (Boil-prep) at room temperature. When glycogen was quantified enzymatically in tissue lysates, no significant differences were found between the STD-prep and the Boil-prep for wild-type, GSD II and GSD III muscles. In contrast, glycogen content for GSD IV muscle in the STD-prep was only 11% of that in the Boil-prep, similar to wild-type values. Similar results were observed in other tissues of GSD IV mice and fibroblast cells from a GSD IV patient. This study provides important information for improving disease diagnosis, monitoring disease progression, and evaluating treatment outcomes in both clinical and preclinical clinical settings for GSD IV. This report should be used as an updated protocol in clinical diagnostic laboratories.

Entities:  

Keywords:  Glycogen quantitation method; Glycogen storage disease type IV; Lafora disease; Polyglucosan body

Year:  2016        PMID: 27344645      PMCID: PMC5110445          DOI: 10.1007/8904_2015_522

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  25 in total

1.  Correction of glycogen storage disease type III with rapamycin in a canine model.

Authors:  Haiqing Yi; Elizabeth D Brooks; Beth L Thurberg; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  J Mol Med (Berl)       Date:  2014-02-08       Impact factor: 4.599

2.  Simple enzymatic determination of polysaccharide (glycogen) content of animal tissues.

Authors:  J C Murat; A Serfaty
Journal:  Clin Chem       Date:  1974-12       Impact factor: 8.327

3.  A rapid enzymic method for glycogen estimation in very small tissue samples.

Authors:  F Huijing
Journal:  Clin Chim Acta       Date:  1970-12       Impact factor: 3.786

4.  The fine structure of glycogen from type IV glycogen-storage disease.

Authors:  C Mercier; W J Whelan
Journal:  Eur J Biochem       Date:  1970-11

5.  Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis.

Authors:  B I Brown; D H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

Review 6.  Glycogen metabolism and glycogen-storage diseases.

Authors:  F Huijing
Journal:  Physiol Rev       Date:  1975-10       Impact factor: 37.312

7.  Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.

Authors:  D D Koeberl; B D Sun; T V Damodaran; T Brown; D S Millington; D K Benjamin; A Bird; A Schneider; S Hillman; M Jackson; R M Beaty; Y T Chen
Journal:  Gene Ther       Date:  2006-05-04       Impact factor: 5.250

8.  Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings.

Authors:  Fanny Mochel; Raphael Schiffmann; Marjan E Steenweg; Hasan O Akman; Mary Wallace; Frédéric Sedel; Pascal Laforêt; Richard Levy; J Michael Powers; Sophie Demeret; Thierry Maisonobe; Roseline Froissart; Bruno Barcelos Da Nobrega; Brent L Fogel; Marvin R Natowicz; Catherine Lubetzki; Alexandra Durr; Alexis Brice; Hanna Rosenmann; Varda Barash; Or Kakhlon; J Moshe Gomori; Marjo S van der Knaap; Alexander Lossos
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

9.  Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance.

Authors:  Baodong Sun; Andrew Bird; Sarah P Young; Priya S Kishnani; Y-T Chen; Dwight D Koeberl
Journal:  Am J Hum Genet       Date:  2007-09-21       Impact factor: 11.025

10.  Overexpression of glycogen synthase in mouse muscle results in less branched glycogen.

Authors:  Bartholomew A Pederson; Anna G Csitkovits; Renee Simon; Jill M Schroeder; Wei Wang; Alexander V Skurat; Peter J Roach
Journal:  Biochem Biophys Res Commun       Date:  2003-06-13       Impact factor: 3.575

View more
  2 in total

1.  Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV.

Authors:  Haiqing Yi; Fengqin Gao; Stephanie Austin; Priya S Kishnani; Baodong Sun
Journal:  Mol Genet Metab Rep       Date:  2016-10-04

2.  An optimized method for tissue glycogen quantification.

Authors:  Kyle J Schaubroeck; Brooks P Leitner; Rachel J Perry
Journal:  Physiol Rep       Date:  2022-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.